Status | Study |
Recruiting |
Study Name: Prognosis and Treatment of Necrotizing Soft Tissue Infections: A Prospective Cohort Study Condition: Necrotizing Soft Tissue Infection Necrotizing Fascitis Date: 2017-04-26 Interventions: Device: Hyperbaric oxygen therapy Hyperbaric oxygen therapy with 100 % oxygen at 1.8 ATA for 2 hours. |
Recruiting |
Study Name: Modulation of Biomarkers in Patients With Flesh-eating Bacterial Infections After With Hyperbaric Oxygen Treatment Condition: Necrotizing Soft Tissue Infection Necrotizing Fasciitis Date: 2015-07-03 |
Enrolling by invitation |
Study Name: Hyperbaric Oxygen Therapy Registry Condition: Air or Gas Embolism Carbon Monoxide Poisoning Date: 2015-05-28 |
Completed |
Study Name: Biomarkers in Patients With Flesh-eating Bacterial Infections Condition: Necrotizing Soft Tissue Infection Necrotizing Fasciitis Date: 2014-06-29 |
Completed |
Study Name: Immunoglobulin for Necrotizing Soft Tissue Infections: a Randomised Controlled Trial Condition: Necrotizing Soft Tissue Infection Necrotizing Fasciitis Date: 2014-04-03 Interventions: Drug: IVIG (Privigen) Three do |
Recruiting |
Study Name: Glyburide Advantage in Malignant Edema and Stroke - Remedy Pharmaceuticals Condition: Ischemic Stroke Malignant Edema Date: 2013-02-14 Interventions: Drug: RP-1127 (Glyburide for Injection) Glyburide (5-chloro-N-(4-[N-(cyclohexylcarbamoyl) sulfamoyl]phen |
Completed |
Study Name: Glyburide Advantage in Malignant Edema and Stroke Pilot Condition: Ischemic Stroke Date: 2010-12-29 Interventions: Drug: RP-1127 (Glyburide for injection) Bolus plus 72 hour IV infusion |